ANA Screen, IFA, with Reflex to Titer and Pattern:
Fasting Required: No
Lab: Quest Diagnostics
Specimen: Blood
Results: Send out to West Hills - Average processing time 3-5 days
Note: Result turnaround times are an estimate and are not guaranteed. Our reference lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.
Description: ANA (Antinuclear Antibodies) is a group of special antibodies produced by a person's immune system when it fails to effectively separate between "self" and "nonself." These autoantibodies attack the body's own cells, causing signs and symptoms such as tissue and organ inflammation, joint and muscle pain, and fatigue.
This immunofluorescence assay (IFA) is often ordered as part of an initial diagnostic evaluation of individuals with clinical suspicion of autoimmune diseases associated with antinuclear antibodies (ANAs). ANAs are associated with several autoimmune diseases, such as systemic lupus erythematosus, systemic sclerosis, mixed connective tissue disease, polymyositis, primary biliary cholangitis, rheumatoid arthritis, juvenile rheumatoid arthritis, Sjogren syndrome, and autoimmune hepatitis. The laboratory evaluation for individuals with clinical suspicion of these autoimmune diseases often begins with an ANA screen.
Alternative Names: FANA, Fluorescent ANA, Progressive ANA, Hep-2, Antinuclear Antibody Screen
Lab: Quest Diagnostics
Specimen: Blood
Results: Send out to West Hills - Average processing time 3-5 days
Note: Result turnaround times are an estimate and are not guaranteed. Our reference lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.
Description: ANA (Antinuclear Antibodies) is a group of special antibodies produced by a person's immune system when it fails to effectively separate between "self" and "nonself." These autoantibodies attack the body's own cells, causing signs and symptoms such as tissue and organ inflammation, joint and muscle pain, and fatigue.
This immunofluorescence assay (IFA) is often ordered as part of an initial diagnostic evaluation of individuals with clinical suspicion of autoimmune diseases associated with antinuclear antibodies (ANAs). ANAs are associated with several autoimmune diseases, such as systemic lupus erythematosus, systemic sclerosis, mixed connective tissue disease, polymyositis, primary biliary cholangitis, rheumatoid arthritis, juvenile rheumatoid arthritis, Sjogren syndrome, and autoimmune hepatitis. The laboratory evaluation for individuals with clinical suspicion of these autoimmune diseases often begins with an ANA screen.
Alternative Names: FANA, Fluorescent ANA, Progressive ANA, Hep-2, Antinuclear Antibody Screen